 |
 |
 |
 |
 |
|||
|
Physicians > Genetic Testing The issues surrounding genetic testing of patients with suspected hereditary pancreatitis or other gene mutations is complex (see discussion by Etamad and Whitcomb). Several major research trials are underway and information will be forwarded to physicians by request by emailing Beth Elinoff. Complete screening of the CFTR gene is available at a fraction of the cost of direct sequencing is now available at Ambry Genetics. Ambry Genetics has now developed a complete pancreatitis panel of genetic testing that covers ALL regions of trypsinogen (PRSS1), pancreatic secretor trypsin inhibitor (SPINK1) and the cystic fibrosis transmembrane conductance regulator (CFTR). Contact information is
|
|
|
DISCLAIMER: This information is designed as a tool for background for pancreatic disorders and is not designed to serve as sole medical advice or meant to replace a full medical evaluation. Please consult your personal physician for additional information before making any changes to your diet, lifestyle, or medical treatment. Updated March 28, 2005 Contact Dr. Whitcomb
for questions or comments about this site.
|
